🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 18 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/04/2013 | 34,82 | 36,09 | 34,14 | 34,43 | +1,12% | 5,60% | 1.730.900 |
| 03/04/2013 | 36,84 | 36,99 | 32,80 | 34,05 | -7,09% | 11,37% | 2.189.800 |
| 02/04/2013 | 36,05 | 36,71 | 35,27 | 36,65 | +2,40% | 3,99% | 1.381.600 |
| 01/04/2013 | 36,79 | 37,48 | 35,30 | 35,79 | -3,14% | 5,93% | 1.391.200 |
| 28/03/2013 | 36,42 | 37,70 | 36,42 | 36,95 | +1,87% | 3,51% | 1.780.200 |
| 27/03/2013 | 35,80 | 36,52 | 34,95 | 36,27 | +0,42% | 4,39% | 1.506.400 |
| 26/03/2013 | 34,77 | 36,55 | 34,47 | 36,12 | +4,21% | 5,98% | 2.333.800 |
| 25/03/2013 | 33,74 | 34,74 | 33,21 | 34,66 | +5,77% | 4,53% | 2.037.000 |
| 22/03/2013 | 33,60 | 33,81 | 32,19 | 32,77 | -2,35% | 4,82% | 1.012.700 |
| 21/03/2013 | 32,99 | 33,95 | 32,80 | 33,56 | +2,41% | 3,49% | 1.203.400 |
| 20/03/2013 | 33,50 | 34,00 | 32,65 | 32,77 | -0,97% | 4,03% | 1.427.200 |
| 19/03/2013 | 34,60 | 34,94 | 32,50 | 33,09 | +0,18% | 7,05% | 2.111.800 |
| 18/03/2013 | 32,00 | 33,60 | 31,90 | 33,03 | +2,42% | 5,31% | 1.654.400 |
| 15/03/2013 | 33,75 | 33,99 | 32,09 | 32,25 | -3,56% | 5,63% | 2.213.300 |
| 14/03/2013 | 31,33 | 34,39 | 31,04 | 33,44 | +7,63% | 10,69% | 4.168.300 |
| 13/03/2013 | 30,52 | 31,32 | 30,30 | 31,07 | +1,47% | 3,34% | 1.176.900 |
| 12/03/2013 | 30,30 | 30,67 | 29,61 | 30,62 | +1,02% | 3,50% | 760.200 |
| 11/03/2013 | 30,43 | 30,60 | 29,92 | 30,31 | -0,39% | 2,23% | 753.200 |
| 08/03/2013 | 30,29 | 31,07 | 29,81 | 30,43 | +0,73% | 4,16% | 1.680.000 |
| 07/03/2013 | 30,18 | 31,70 | 29,53 | 30,21 | -3,51% | 7,19% | 2.424.400 |
| 06/03/2013 | 30,80 | 31,74 | 30,27 | 31,31 | +2,89% | 4,77% | 1.728.100 |
| 05/03/2013 | 30,74 | 31,73 | 29,60 | 30,43 | +1,20% | 6,93% | 2.297.100 |
| 04/03/2013 | 30,37 | 30,92 | 28,35 | 30,07 | +1,62% | 8,46% | 2.318.000 |
| 01/03/2013 | 28,88 | 30,00 | 28,35 | 29,59 | +0,99% | 5,71% | 1.957.500 |
| 28/02/2013 | 31,57 | 32,00 | 29,02 | 29,30 | -7,01% | 9,44% | 2.155.200 |
| 27/02/2013 | 29,18 | 32,40 | 28,96 | 31,51 | +8,54% | 11,79% | 3.849.100 |
| 26/02/2013 | 28,61 | 29,75 | 28,53 | 29,03 | +1,79% | 4,26% | 1.192.200 |
| 25/02/2013 | 27,85 | 29,07 | 27,70 | 28,52 | +2,48% | 4,92% | 989.100 |
| 22/02/2013 | 27,51 | 27,89 | 27,09 | 27,83 | +0,80% | 2,91% | 674.300 |
| 21/02/2013 | 27,96 | 28,55 | 26,88 | 27,61 | +0,51% | 5,97% | 1.365.200 |